Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study

J Eur Acad Dermatol Venereol. 2024 Sep;38(9):e743-e746. doi: 10.1111/jdv.19862. Epub 2024 Feb 8.
No abstract available

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Asthma* / complications
  • Asthma* / drug therapy
  • Dermatitis, Atopic* / complications
  • Dermatitis, Atopic* / drug therapy
  • Female
  • Heterocyclic Compounds, 3-Ring* / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Rhinitis, Allergic* / complications
  • Rhinitis, Allergic* / drug therapy
  • Severity of Illness Index

Substances

  • Heterocyclic Compounds, 3-Ring
  • upadacitinib